An interventional study of Community-led discussion in COVID-19 and Trust, sponsored by Old Dominion University. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-11.
Sponsored by Old Dominion University · Not applicable, Interventional, and Prevention
The goal of this adapted intervention study is to assess how community-led group discussions about health-related topics may alter beliefs and intentions regarding healthcare recommendations, such as COVID-19 testing and vaccination.
Eligible participants were randomized to intervention or control group. Intervention group participants met virtually with other community member participants in small discussion groups once a week for 75 minutes over the course of 14 weeks. The online discussion groups were led by peer mentor facilitators and supported by a research team member. Discussion topics included current events and other health related topics. Control group participants did not meet in weekly discussion groups. At approximately the 0 weeks, 14 weeks, and 18 weeks time points, all participants answered online surveys about health related topics. At the 14 weeks and 18 weeks time points, all participants were asked to self-administer a COVID-19 test that investigators provide.
7,990 studies on the registry are indexed under COVID-19; 466 are open to participants now.
This study's enrollment of 49 is below the median of 102 across 4,364 interventional studies indexed under COVID-19.
Browse COVID-19 studies →Old Dominion University is the lead sponsor of 27 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
non-intervention control (participants complete surveys only)
Participants engage in weekly community-led small group discussions about health-related topics and answer surveys at 0, 14, and 18 week time points
Behavioral: Community-led discussion
Participants engage in weekly community-led small group discussions about health related topics
Openness to COVID-19 Testing
The COVID-19 Testing Openness Questionnaire is an 7-item self-report measure designed to assess participants' openness to getting tested for COVID-19. Each item is rated on a 5-point scale, from 1 "Strongly Disagree" to 5 "Strongly Agree," with the sum of scores ranging from 7 to 35. Higher scores indicate greater openness to COVID-19 testing.
Time frame: 0 weeks, 14 weeks, 18 weeks
COVID-19 Testing Efficacy
The COVID-19 Testing Efficacy Scale is a 6-item self-report measure that will assess participants' perceived self- and response-efficacy related to COVID-19 testing. Each item is rated on a 5-point scale ranging from 1 "Strongly Disagree" to 5 "Strongly Agree," with the sum of scores ranging between 6 and 30. Higher scores indicate greater efficacy.
Time frame: 0 weeks, 14 weeks, 18 weeks
Trust in the Safety of the COVID-19 Vaccine
Trust in the safety of the COVID-19 vaccine was measured with one item which assessed participants' trust in the safety of the COVID-19 vaccine. The item is rated on a 5-point Likert scale. Higher scores indicate greater trust.
Time frame: 0 weeks, 14 weeks, 18 weeks
Trust in Efficacy of the COVID-19 Vaccine
Trust in the efficacy of the COVID-19 vaccine was measured with one item which assessed participants' perceptions of efficacy related to the COVID-19 vaccine, or trust that it works as intended. The item is rated on a 5-point Likert scale. Higher scores indicate greater trust.
Time frame: 0 weeks, 14 weeks, 18 weeks
COVID-19 Vaccine Hesitancy
Vaccine Hesitancy was assessed by an item that asked, "Overall, how hesitant about the COVID-19 vaccine would you consider yourself to be?." This question was adapted from the Parent Attitudes about Childhood Vaccines (PACV) survey. The item is scored on a 5-point Likert scale, ranging from "1 - not at all hesitant" to "5 = very hesitant" with higher scores indicating greater hesitancy.
Time frame: 0 weeks, 14 weeks, 18 weeks
Social Connectedness
The Social Connectedness Scale Revised is a 20-item scale that measures a participant's feeling of connection with other people and their community. Each item is rated on a 6-point scale ranging from 1 "Strongly Disagree" to 6 "Strongly Agree," with the sum of scores ranging between 20 and 120. Higher scores indicate greater connectedness.
Time frame: 0 weeks, 14 weeks, 18 weeks
Health Literacy
The Health Literacy Scale (HLS-14) for Adults is a 14-item scale adapted for use in the US that measures an individual's ability to understand, access, and apply health-related information. Each item is rated on a 5-point scale ranging from 1 "Strongly Disagree" to 5 "Strongly Agree," with the sum of scores ranging between 14 and 70. Higher scores indicate greater health literacy.
Time frame: 0 weeks, 14 weeks, 18 weeks
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Jul 2025 to primary completion in Jan 2026, 6 months.
Of 1,338 non-industry interventional studies with no phase under COVID-19, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 20. This study's 6 months is below that.
Counting every sponsor, half of 1,476 studies reached it within 9 months; a quarter within 3 and three quarters within 19.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Old Dominion University